OGT and prostate cancer: Indeed, combined treatment of prostate cancer cells with OGT inhibitor and the CDK9 inhibitor NVP2 induced the accumulation of p-H2AX in PC and CRPC cells but not in the normal prostate cells (Fig. 4C).